» login

loading

Please sign in

Non-invasive assessment of cardiovascular risk and risk of diabetes

Clinically validated, convenient and easy to use

AGEs play a pivotal role in the development of chronic age-related diseases such as diabetes, renal failure and cardiovascular disease.

  • Harmfull compounds
  • Related to ageing
  • Glycaemic memory
  • CV complications
read more

Cardiovascular risk

CV risk assessment Cardiovasculair risk

It is critical to assess the individual cardiovascular risk of your patients. Finding high risk patients early allows doctors to adjust treatement as soon as possible.

  • Diabetes
  • Renal failure
  • Atherosclerosis
  • Other diseases
read more
"AGE Reader measurements allow for a quantification of the AGEs load and show good predictive value for the development of diabetic complications" Stirban & Heinemann (2014)
Latest news

Diagnoptics appoints ANL Produkter AB as new Swedish distributor

Groningen, the Netherlands – December 8, 2014 Diagnoptics appointed ANL Produkter AB as the new distributor of its products in Sweden. ANL Produkter AB ......

» read more

The AGE Reader and Diab-spot have received approval in a number of countries. Please check with the distributor in your country or DiagnOptics what the regulatory approval status is in your country. US Caution: Federal law restricts the AGE Reader and Diab-spot system to investigational use only. Commercial distribution has not been granted by the US FDA. Please see the AGE Reader and Diab-spot user manuals for descriptions of all relevant warnings, cautions, contraindications and safety information.

About the company

Find information about DiagnOptics.

Information for patients

Find information about DiagnOptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.